Financials
13F History
Stockholders: BMO, FNGU, FNGS, BULZ, GDXD, FNGD, FNGO, GDXU, GDXU, OILD, JETU
Other Reports

BANK OF MONTREAL /CAN/

Holdings History for Sage Therapeutics, Inc. - COM (SAGE)

Symbol: SAGE on Nasdaq
Investment type: Equity - Shares of Stock
Class: COM

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Option	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2022			0%	$0	0	-41,421	-100%		Q3 2022
6/30/2022		0%	+0%	$1.49M	41.4K	+31,757	+329%	$36.02	Q2 2022
3/31/2022				$2K	44			$45.45^*	Q1 2022
3/31/2022		0%	0%	$334K	9.66K	-18,676	-65.9%	$34.56	Q1 2022
12/31/2021		0%	0%	$1.23M	28.3K	-169,781	-85.7%	$43.26	Q4 2021
9/30/2021		0%	+0%	$8.92M	198K	+198,121	NEW	$45.03	Q3 2021
6/30/2021			0%	$0	0	-3,379	-100%		Q2 2021
3/31/2021		0%	+0%	$261K	3.38K	+80	+2.42%	$77.24	Q1 2021
12/31/2020		0%	0%	$300K	3.3K	-116	-3.4%	$90.94	Q4 2020
9/30/2020		0%	+0%	$218K	3.42K	+1,598	+87.9%	$63.84	Q3 2020
9/30/2020	call		-0.02%	$0	0	-20,000	-100%		Q3 2020
6/30/2020		0%	+0%	$79K	1.82K	+707	+63.7%	$43.48	Q2 2020
6/30/2020	call	0.02%	+0.02%	$882K	20K	+20,000	NEW	$44.10	Q2 2020
3/31/2020		0%	0%	$30K	1.11K	-1,947	-63.7%	$27.03	Q1 2020
12/31/2019		0%	0%	$221K	3.06K	-7,314	-70.5%	$72.29	Q4 2019
9/30/2019		0%	0%	$1.46M	10.4K	-4,668	-31%	$140.30	Q3 2019
6/30/2019		0%	+0%	$2.75M	15K	+9,524	+173%	$183.06	Q2 2019
3/31/2019		0%	0%	$877K	5.52K	-698	-11.2%	$159.02	Q1 2019
12/31/2018		0%	+0%	$596K	6.21K	+66	+1.07%	$95.93	Q4 2018
9/30/2018		0%	+0%	$868K	6.15K	+1,113	+22.1%	$141.21	Q3 2018
6/30/2018				$1K	8			$125.00^*	Q2 2018
6/30/2018		0%	+0%	$788K	5.03K	+4,661	+1250%	$156.54	Q2 2018
3/31/2018		0%	+0%	$60K	373	+37	+11%	$160.86	Q1 2018
12/31/2017		0%	+0%	$55K	336	+236	+236%	$163.69	Q4 2017
9/30/2017		0%	0%	$6K	100	-104	-51%	$60.00	Q3 2017
6/30/2017		0%	0%	$16K	204	-11,802	-98.3%	$78.43	Q2 2017
3/31/2017		0%	+0%	$853K	12K	+11,837	+7004%	$71.05	Q1 2017
12/31/2016		0%	+0%	$8K	169	+115	+213%	$47.34	Q4 2016
9/30/2016		0%		$2K	54			$37.04	Q3 2016
6/30/2016				$2K	54			$37.04^*	Q2 2016
3/31/2016		0%		$4K	135			$29.63	Q1 2016
12/31/2015		0%		$8K	135			$59.26	Q4 2015
9/30/2015		0%	0%	$6K	135	-1,865	-93.3%	$44.44	Q3 2015
6/30/2015		0%	+0%	$146K	2K	+2,000	NEW	$73.00	Q2 2015

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.